In Steve Fox’s third appearance on Fox & Friends, he discusses the passage of Arizona’s Proposition 203. At the end of this “fair and balanced” debate, Mr. Fox is cut off before he can respond to some extremely dubious statements. Read Mr. Fox’s rebuttal after the video.
From Steve Fox:
The closing argument by Paul Charlton about MPP’s disinterest in seeing marijuana go through the FDA approval process was both inaccurate and uninformed. Since 2002, MPP has engaged in a wide range of lobbying efforts in an attempt to pressure the DEA into granting a license to the University of Massachusetts to cultivate marijuana for FDA-approved research. Currently, anyone who wants to conduct research on the therapeutic benefits of marijuana must seek permission from the National Institute on Drug Abuse to acquire marijuana from the only federally-approved marijuana farm in the country at the University of Mississippi. But no corporation or organization would be able to use this marijuana for testing purposes and then bring the product to market, since they would not have control of the substance nor would they be able to prove that they could reproduce it.
Popular VideoThis young teenage singer was shocked when Keith Urban invited her on stage at his concert. A few moments later, he made her wildest dreams come true.
A separate marijuana cultivation facility, which could effectively work with a private company or organization to develop and test a specific strain of marijuana, is needed in order to navigate the FDA process and bring a marijuana-based product to market. Yet the DEA has intentionally blocked the University of Massachusetts application for eight years, despite the fact that an administrative law judge within the DEA ruled in 2007 that granting the license would be “in the public interest.”
If Mr. Charlton is truly interested in allowing science to determine whether marijuana is a medicine, he should join MPP in calling on the DEA to award the cultivation license to the University of Massachusetts. If he isn’t willing to do that, he needs to find a new — and accurate — talking point.